Article
Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
Human vaccines & immunotherapeutics - 31 Dec 2022
Kozawa Kei, Higashimoto Yuki, Kawamura Yoshiki, Miura Hiroki, Negishi Takumi, Hattori Fumihiko, Ihira Masaru, Komoto Satoshi, Taniguchi Koki, Yoshikawa Tetsushi
Abstract excerpt
Rotavirus (RV) is a leading cause of gastroenteritis in children. In Japan, Rotarix (RV1; GlaxoSmithKline), which is a monovalent vaccine derived from human RV (G1P[8]), has been introduced since November 2011, and RotaTeq (RV5; MSD) which is an pentavalent, human-bovine mono-reassortant vaccine (G1, G2, G3, G4, and P1A[8]), has been introduced since July 2012. Long-term follow-up on vaccine efficacy and RV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
